Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Adv Neonatal Care ; 17(5): 331-336, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28938264

RESUMEN

The National Association of Neonatal Nurse Practitioners (NANNP) conducted its second workforce survey of certified neonatal nurse practitioners in the fall of 2016. National Association of Neonatal Nurse Practitioners partnered with the National Certification Corporation and the American Association of Nurse Practitioners to conduct this electronic survey, containing 69 questions and focusing on practice sites and total compensation packages (including benefits) and workforce deficits.Findings indicate a rising neonatal nurse practitioners (NNPs) position vacancy rate across the country. Regional salary data indicated that the southeast had lower compensation rates for NNPs, with regions 4 and 11 (South) having the lowest rates. A promising trend indicated that new graduate NNPs with a doctorate are earning more. The study findings indicate that tailoring benefit packages to the age and years of experience for the individual NNP may aid in recruiting and retaining NNPs in practice. For experienced NNPs, altered shift lengths (shorter), higher employer matching rates in retirement plans, and less employee cost sharing for health insurance benefits are more appealing strategies.It is critical for NNPs to continually evaluate the profession's workforce data. There are more than 205,000 nurse practitioners practicing in the United States, with neonatal NPs making up approximately 3% of the larger whole. Increased participation in future surveys will assist in creating sustainable solutions to the workforce crisis facing the profession.


Asunto(s)
Enfermeras Practicantes , Enfermeras Neonatales , Admisión y Programación de Personal , Salarios y Beneficios , Seguro de Costos Compartidos , Escolaridad , Femenino , Humanos , Seguro de Salud , Masculino , Persona de Mediana Edad , Pensiones , Selección de Personal , Encuestas y Cuestionarios , Estados Unidos
2.
Adv Neonatal Care ; 14(1): 24-9, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24472885

RESUMEN

Nonlethal Escobar is a rare disorder that is a variant of multiple pterygium syndromes. It is a form of arthrogryposis multiplex congenita characterized by excessive webbing (pterygia), congenital contractures (arthrogryposis), and scoliosis. It is usually diagnosed in utero on fetal ultrasound and then confirmed in the neonatal period. A case of nonlethal neonatal Escobar is reported in a 35-week-and-6-day old infant who presented in utero with decreased fetal movement, oligohydramnios, and arthrogryposis. The etiologies from maternal causes were excluded prior to birth. Subsequent workup after birth led to a highly suspected diagnosis of nonlethal Escobar by the geneticist. The diagnosis was confirmed by a positive CHRNG gene sequence analysis after discharge. The infant demonstrated contractures and bilateral hip subluxation but was feeding well and was discharged home with outpatient follow-up. Treatment after discharge has been extensive secondary to difficulties associated with this disease. The clinical presentation of nonlethal Escobar, as well as diagnosis and treatment strategies, is provided with caregiving strategies.


Asunto(s)
Anomalías Múltiples/diagnóstico , Artrogriposis/diagnóstico , Hipertermia Maligna/diagnóstico , Anomalías Cutáneas/diagnóstico , Anomalías Múltiples/genética , Artrogriposis/genética , Femenino , Humanos , Recién Nacido , Hipertermia Maligna/genética , Receptores Nicotínicos/genética , Anomalías Cutáneas/genética
4.
Adv Neonatal Care ; 13(1): 22-8; quiz 29-30, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23360855

RESUMEN

There exists general agreement within neonatology that antibiotics should be administered promptly to neonates with possible bacterial sepsis and meningitis. We initiated a series of quality improvement cycles designed to reduce delays in the initiation of antibiotic therapy to less than 2 hours when hospital-acquired infection (HAI) was suspected. All infants in this study were in neonatal intensive care (level II or III) who were started on antibiotics for a suspected HAI (defined as an infection that occurred 72 hours after admission to the NICU) were audited. Through a series of quality improvement cycles, we analyzed sources of delays in the initiation of antibiotic therapy from the time the order was written through administration. In subsequent cycles, we intervened to reduce delays through education, standardize the evaluation process, and develop an online ordering system that streamlined the workflow patterns in the nurseries and pharmacy. Using a prospective cohort design, we compared antibiotic delivery times after each process improvement cycle. Antibiotic delivery time was reduced from a median of 137.5 minutes to 75 minutes and variation of practice was reduced in terms of standard deviation and range (P < .001). The use of computerized physician order entry significantly improved the writing of STAT orders (P < .0001). A systematic analysis of workflow patterns and efficiencies, coupled with improvement cycles targeting delays and development of a computerized physician order entry system, allowed us to improve antibiotic delivery time in neonates with suspected HAI in an intensive care nursery system.


Asunto(s)
Antibacterianos/administración & dosificación , Infección Hospitalaria/tratamiento farmacológico , Evaluación de Síntomas/métodos , Administración del Tiempo , Tiempo de Tratamiento , Infección Hospitalaria/clasificación , Infección Hospitalaria/diagnóstico , Humanos , Lactante , Recién Nacido , Unidades de Cuidado Intensivo Neonatal/organización & administración , Cuidado Intensivo Neonatal/métodos , Cuidado Intensivo Neonatal/normas , Evaluación de Procesos y Resultados en Atención de Salud , Guías de Práctica Clínica como Asunto , Evaluación de Programas y Proyectos de Salud , Estudios Prospectivos , Mejoramiento de la Calidad , Administración del Tiempo/métodos , Administración del Tiempo/organización & administración , Tiempo de Tratamiento/organización & administración , Tiempo de Tratamiento/normas
5.
Adv Neonatal Care ; 11(3): 167-72, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21730909

RESUMEN

Congenital central hypoventilation syndrome (CCHS) is a relatively rare, life-threatening, and lifelong multisystem disorder characterized by autonomic nervous system dysfunction, which mostly manifests as failure to maintain ventilatory homeostasis during sleep. Infants with CCHS have inadequate sensitivity to hypoxia and hypercapnia during sleep and in some cases during wakefulness, leading to persistent apnea. This article reports a case of CCHS in a 38-week-gestation infant who presented on day of life 2 with persistent apnea. Diagnosis of primary pulmonary, cardiac, metabolic, neurologic disease, or injury was excluded before the diagnosis of CCHS was made. The diagnosis was confirmed by a PHOX2B sequence analysis. A tracheotomy was performed and the infant was discharged home on a home ventilator with outpatient follow-up. The clinical presentation of CCHS, as well as diagnosis and treatment strategies, is reviewed.


Asunto(s)
Hipoventilación/congénito , Apnea Central del Sueño/diagnóstico , Diagnóstico Diferencial , Femenino , Proteínas de Homeodominio/genética , Humanos , Hipoventilación/diagnóstico , Hipoventilación/genética , Hipoventilación/enfermería , Hipoventilación/terapia , Recién Nacido , Análisis de Secuencia , Apnea Central del Sueño/genética , Apnea Central del Sueño/enfermería , Apnea Central del Sueño/terapia , Traqueotomía , Factores de Transcripción/genética , Resultado del Tratamiento , Ventiladores Mecánicos
7.
Adv Neonatal Care ; 10(5): 230-8, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20838071

RESUMEN

The survival of very low-birth-weight (VLBW) infants has been shown to be effected by alterations in thermoregulation. Morbidity and mortality in these VLBW infants has remained higher than those in any other group of infants because of their innate vulnerability and because of exposure to risk factors in the environment. This leaves the premature infant vulnerable to cold stress especially in the first hours to weeks of life. At birth, the VLBW infant emerges from a warm, fluid environment and is thrust into a cold, abrasive environment before the protective layers of the epidermis have developed. Within minutes of birth, the core temperature begins to fall, particularly in infants whose birth weights are less than 1500 g. Hypothermia is a major cause of morbidity and mortality in infants; therefore, maintaining normal body temperatures in the delivery room is crucial. We reviewed evidence related to thermoregulation at birth in VLBW infants, including transepidermal water loss and temperature control in the delivery room, during stabilization and upon admission to the neonatal intensive care unit. Delivery room management that focuses on the adaptation of the infant as well as early interventions that improve long-term outcomes may emphasize the "golden hour" of care and improve outcomes in this extremely vulnerable population.


Asunto(s)
Regulación de la Temperatura Corporal/fisiología , Frío/efectos adversos , Salas de Parto , Hipotermia/prevención & control , Recien Nacido Prematuro/fisiología , Recién Nacido de muy Bajo Peso/fisiología , Cuidado Intensivo Neonatal/métodos , Ambiente Controlado , Ambiente de Instituciones de Salud , Humanos , Recién Nacido , Guías de Práctica Clínica como Asunto , Factores de Tiempo
9.
Adv Neonatal Care ; 9(2): 72-6, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19363327

RESUMEN

Neonatal hemochromatosis is a rare disease of iron metabolism, characterized by the excess accumulation of iron in the tissues. This occurs in utero and can lead to fetal demise or an infant who presents with advanced liver disease in the neonatal period. A case of neonatal hemochromatosis is reported in a 37-week infant who presented at birth with thrombocytopenia, coagulopathy, and abnormal liver imaging studies. The diagnoses of infection and metabolic errors were excluded before the confirmation of neonatal hemochromatosis was made. This diagnosis was confirmed by elevated ferritin levels and extrahepatic siderosis excluding the reticuloendothelial system. Anti-oxidant therapy was initiated with N-acetyl cysteine, selenium, vitamins C and E and intravenous immunoglobulin. The infant demonstrated a positive response and was discharged home with outpatient follow up. The clinical presentation of neonatal hemochromatosis is reviewed as well as diagnosis and treatment strategies.


Asunto(s)
Hemocromatosis/diagnóstico , Fallo Hepático Agudo/complicaciones , Fallo Hepático Agudo/diagnóstico , Adulto , Antioxidantes/administración & dosificación , Diagnóstico Diferencial , Femenino , Hemocromatosis/sangre , Hemocromatosis/tratamiento farmacológico , Hemocromatosis/enfermería , Humanos , Inmunoglobulinas Intravenosas/administración & dosificación , Recién Nacido , Unidades de Cuidado Intensivo Neonatal , Fallo Hepático Agudo/sangre , Masculino , Embarazo , Complicaciones del Embarazo/sangre , Complicaciones del Embarazo/diagnóstico , Resultado del Tratamiento , alfa-Fetoproteínas/análisis
11.
J Perinatol ; 24(10): 663-6, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15229621

RESUMEN

Surfactant treatment has become the standard of care in premature infants with respiratory distress syndrome (RDS). Pulmonary hemorrhage, pulmonary edema, pneumonia, and atelectasis have been shown to liberate inflammatory mediators and plasma proteins, which damage type II pneumocytes and inactivate surfactant. These disease processes may, therefore, lead to a secondary surfactant inactivation or deficiency, which can be an unrecognized cause of respiratory decompensation after initial recovery from RDS in this vulnerable population. This is a descriptive report of three cases, which had acute respiratory decompensation between 1 and 3 weeks of age. All three infants demonstrated a response to secondary doses of surfactant. We submit that the diagnosis and treatment of secondary surfactant deficiency in the critically ill premature neonate warrants further study.


Asunto(s)
Recien Nacido Prematuro , Surfactantes Pulmonares/uso terapéutico , Síndrome de Dificultad Respiratoria del Recién Nacido/diagnóstico , Adulto , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Oxigenación por Membrana Extracorpórea , Femenino , Estudios de Seguimiento , Edad Gestacional , Humanos , Recién Nacido , Masculino , Embarazo , Surfactantes Pulmonares/metabolismo , Síndrome de Dificultad Respiratoria del Recién Nacido/sangre , Síndrome de Dificultad Respiratoria del Recién Nacido/terapia , Pruebas de Función Respiratoria , Medición de Riesgo , Muestreo , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA